Device Structural Heart

Navitor

Payments companies reported to CMS as associated with Navitor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.5Massociated payments (2023-2025)
3,135clinicians with associated payments
1company reporting

By year

2023 $144K
2024 $711K
2025 $1.6M

Payments reported as associated with Navitor, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $1.3M
Thoracic Surgery (Cardiothoracic Vascular Surgery) $429K
Cardiovascular Disease $264K
Family $70K
Physician Assistant $66K
Nurse Practitioner $52K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Navitor

These are the largest totals companies reported as associated with Navitor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Nishant Sethi Scranton, PA Interventional Cardiology $228,278.33
Ganesh Keshav Thirunavukkarasu Lexington, KY Interventional Cardiology $110,000.00
Vinayak Bapat Minneapolis, MN Thoracic Surgery (Cardiothoracic Vascular Surgery) $99,739.83
Rishi Puri Cleveland, OH Interventional Cardiology $55,151.62
Luigi Pirelli New York, NY Thoracic Surgery (Cardiothoracic Vascular Surgery) $50,955.60
Paul Mahoney Greenville, NC Interventional Cardiology $47,624.69
Matthew Summers Norfolk, VA Interventional Cardiology $46,507.80
Mohamed Azeem Latib Bronx, NY Interventional Cardiology $46,499.29
Pradeep Yadav Atlanta, GA Interventional Cardiology $43,637.07
Brian Kolski Orange, CA Interventional Cardiology $38,265.46

Prescribed Navitor?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.